The neuroprotective role of astrocytic GJIC and Cx43 has been controversial and challenged by in vitro ischemia studies using gap-junctional blockers such as carbenoxolone (CBX), octanol, and halothane that showed not only a decreased infarct volume but also a significant reduction in neuronal cell death [226,228]. Here, GJA1 is linked to ischemia.